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Spontaneous neonatal aortic thrombus is rare. Clinical presentation can vary depending on the location
of the thrombus. We report a case of a premature infant with ischemic bowel likely due to an aortic
thromboembolic event. The infant had presented with an acute abdomen, and underwent an exploratory
laparotomy for concerns of worsening necrotizing enterocolitis. Intra-operative ﬁndings were suggestive
of segmental ischemic small bowel with thrombosis of mesenteric vessels and a subsequent Doppler
ultrasound revealed an infra-renal aortic thrombus. He was treated with subcutaneous enoxaparin, with
effective reduction in thrombus size on serial scans. However, this treatment was complicated by
bilateral subdural hematoma, and hence enoxaparin was discontinued. Aortic thrombus, although rare,
should be considered in the differential diagnosis of an acute abdomen. Management of neonatal aortic
thrombus remains controversial and further studies are required to aid clinicians in deciding the best
management plan with minimal risk and optimal outcome.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).In a premature neonate presenting with abdominal distension
and abdominal wall erythema, the most likely differential diagnosis
would naturally be necrotizing enterocolitis (NEC). However, other
less common causes such as aortic thrombus should also be
considered. We present a case with a similar presentation attrib-
uted to bowel ischemia likely secondary to an infra-renal aortic
thrombus.1. Case report
This is a premature neonatewith gestational age of 25þ 6weeks
who was born to a 27-year-old Gravida 1 Para 0 mother. Her
antenatal history was complicated by cervical incompetence at
23þ 1 weeks and she had undergone cervical cerclage. The neonate
was delivered prematurely in view of maternal chorioamnionitis as
well as preterm labor.
His post-natal course was complicated by hyaline membrane
disease requiring intubation and surfactant. He also had a large
patent ductus arteriosus (PDA) complicated by pulmonary hemor-
rhage that failed 2 courses of Indomethacin and eventually requiredg).
Inc. This is an open access article uPDA ligation. He was then extubated to nasal intermittent manda-
tory ventilation (NIMV) on day 37 of life, and converted to contin-
uous positive airway pressure (CPAP) on day 50 of life. In his
immediate post-natal period, an umbilical arterial catheter (UAC)
was inserted and it was removed after 7 days.
On day 72 of life, the infant was noted to have marked respira-
tory distress associated with desaturations and abdominal disten-
sion. He was kept nil by mouth (NBM), intubated and even required
escalation to high frequency oscillatory ventilation (HFOV). Blood
investigations revealed a high C-reactive protein (CRP) with neu-
tropenia and thrombocytopenia requiring platelet transfusions. He
was started on intravenous (IV) Cloxacillin, Amikacin and Metro-
nidazole, and subsequently expanded to broader coverage with
Meropenem, IV Gentamicin and IV Vancomycin.
The infant was also referred to the Pediatric surgeons in view of
possible necrotizing enterocolitis (NEC) versus septic ileus. Serial
abdominal X-rays (AXR) showed distended bowel loops but no
obvious intramural gas (Fig. 1). However, the abdominal distension
worsened and was associated with peri-umbilical and ﬂank ery-
thema with absent bowel sounds. He subsequently became hypo-
tensive, requiring ﬂuid boluses and inotropic support with
dopamine infusion. An abdominal ultrasound showed free intra-
peritoneal ﬂuid and inter-loop ﬂuid with internal echoes and sep-
tations likely due to intra-abdominal infection. In view ofnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. AXR showing distended bowel loops.
Fig. 2. Intra-operative ﬁnding of dilated proximal bowel and ischemic bowel segment.
Fig. 3. Resected non-viable ischemic bowel segment.
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abdominal wall erythema, along with an increasing trend of CRP
from 120 to 265, the infant underwent exploratory laparotomy on
day 74 of life.
The intra-operative ﬁndings revealed 48 cm of dilated, ischemic,
non-viable small bowel which was resected. The segment was thin-
walled with no visible peristalsis, and no perforations were noted.
The supplying mesenteric vessel was found to be thrombosed,
resulting in a wedge-shaped pattern of mesenteric infarction
(Figs. 2e4). An ileostomywas created, and the infanthada remainder
of healthy proximal 50 cm of small bowel from the duodeno-jejunal
junction as well as 18 cm of terminal ileum distal to the resected
margin, with preservation of the ileo-cecal valve. Post-operatively,
the infantwas kept nil bymouth (NBM) for 10 days before feedswere
restarted and increased gradually as tolerated. However, his feeding
was complicated by persistently high stoma output once he reached
100 mls/kg/day, and distal refeeding was initiated.
In view of the interesting ﬁnding of a thrombosed mesentery
along with ischemic gut with no evidence of NEC, further in-
vestigations were conducted to search for evidence of intra-
abdominal thrombi. A Doppler abdominal ultrasound showed a
1.1 cm long echogenic focus in the lumen of the infra-renal aorta
which is suspicious for thrombus (Fig. 5). A repeat ultrasound one
week after showed that the thrombus had grown to 2.2 cm. As such,
decision was made to initiate treatment with subcutaneous enox-
aparin. Prior to starting Enoxaparin, blood tests and a cranial
ultrasound were done to ensure normal platelet levels and coagu-
lation proﬁle as well as absence of any intracranial hemorrhage. Of
note, a 2D echocardiogram done on the day prior to the laparotomydid not demonstrate any evidence of right atrial thrombous or
coarctation of the aorta (Fig. 5).
It took 5 days to achieve therapeutic levels of anti-Factor Xa
within 0.5e1.0 IU/ml, requiring a dose of 4.6 mg/kg/day of
Enoxaparin given 12 hourly. Once treatment with Enoxaparin was
initiated, the size of the thrombus remained stable. Anti-Factor Xa
levels and platelet levels were monitored weekly. However, a cra-
nial ultrasound done one month after starting treatment with
Enoxaparin showed a left subdural hematoma measuring
Fig. 4. Intra-operative ﬁnding of thrombosed mesentery.
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therapeutic range as well as normal platelet levels. Given such
complication, enoxaparin was discontinued. Weekly serial Doppler
abdominal scans showed gradual reduction of the size of the
thrombus, with the latest size being 1.3 cm. A follow-up cranial
ultrasound three weeks later demonstrated a small right subdural
hematoma as well, with the previously noted left subdural hema-
toma being stable in size. There were no other bleeding manifes-
tations noted.
The infant underwent stoma closure on day 142 of life and is
currently stable. A repeat Doppler ultrasound done at corrected ageFig. 5. Doppler ultrasound showing echogenic focus in the aorta suspicious for aortic
thrombus.of about 9 months showed a fairly stable non-occluding echogenic
thrombus measuring 0.2 cm. The latest Doppler ultrasound done at
corrected age of 1 year old showed no further evidence of the aortic
thrombus.2. Discussion
Neonatal arterial thrombosis is rare, and the incidence of
symptomatic neonatal arterial thromboembolic disease has been
reported to be 0.25 out of 10,000 live births [1]. Neonates tend to be
in a physiological ‘relative’ pro-thrombotic state due to their
immature hemostatic systems, thus increasing their susceptibility
to thrombosis [2].
In the above case, given the surgical operative ﬁndings as well as
ultrasound results, we postulate that the small bowel ischemia is
secondary to the aortic thrombus, which had initially been causing
mesenteric ischemia and may have subsequently migrated during
or after the surgery to the infra-renal region of the aorta.
In neonates, up to 90% of arterial thrombosis are associated with
arterial access devices [1]. A prospective study found that arterial
thromboses were found in 23.4% of 47 babies who had a UAC
inserted, althoughmajority of these infants were asymptomatic [2].
The pathophysiology of thrombosis is related to vascular obstruc-
tion, endothelial damage by the catheter and low blood ﬂow [3].
Spontaneous arterial thromboses are extremely rare and tend to be
severe and mostly involve the aorta [2].
Apart from arterial access catheters, critical illness is also a well-
recognized risk factor for thromboembolism due to the develop-
ment of a pro-thrombotic state as coagulation inhibitors are being
consumed [4]. Several other factors predisposing a neonate to
thrombosis include congenital thrombophilia, congenital heart
disease, dehydration, polycythemia and surgery [2,4].
In our infant, the cause of the aortic thrombus is unclear, but he
did have risk factors that may possibly have contributed to for-
mation of the thrombus, including UAC insertion, presumed sepsis
and PDA ligation. His UAC was removed on day 7 and the clinical
episode occurred on day 72 of life. Even though it is difﬁcult to
conclude whether the UAC could have been the source of the
thrombus, a slowly evolving thrombus with subsequent emboli-
zation cannot be ruled out. Sepsis could be a potential cause, but
blood cultures returned negative.
The clinical presentation of arterial thrombosis depends on the
location of the thrombus, and include:
 Signs of limb ischemia (e.g. Pale or cold extremities, weak or
absent pulses) especially related to cases of arterial catheteri-
zation of peripheral or central arteries
 Signs similar to that of necrotizing enterocolitis (e.g. Feed intol-
erance, bilious gastric aspirates, blood-stained stools) suggesting
mesenteric infarction
 Increased blood pressure suggesting renal artery thrombosis
 Signs suggestive of arterial ischemia stroke (e.g. Seizures, leth-
argy) [4]
Management of an arterial thrombus still remains controversial,
as published data in the literature is limited to small case series or
case studies. A Cochrane review also did not provide any conclu-
sions as no eligible studies were found [5]. The management
includes clinical observation, anticoagulation, thrombolytic therapy
or surgical thrombectomy. If the patient were asymptomatic, clin-
ical observation may be indicated, but close regular monitoring is
required and anticoagulation initiated if the clot were to enlarge [6].
With regards to anticoagulation, low molecular weight heparin
(LMWH) is increasingly being used as compared to unfractionated
heparin as it allows for subcutaneous application and has a lower
C.Y. Ting et al. / J Ped Surg Case Reports 4 (2016) 42e45 45incidence of bleeding [6]. Preterm infants tend to require a longer
time for anti-Factor Xa levels to reach target range as compared to
term infants (6 versus 2 days) and also tend to require higher doses
of enoxaparin (2.1 mg/kg/dose 12 hourly versus 1.7 mg/kg/dose 12
hourly) [4], as seen with our case. This might be due to neonates
having a reduced response to heparin due to their low levels of anti-
thrombin and a higher rate of heparin clearance [2].
Thrombolysis should only be considered in cases of limb or
organ-threatening thrombosis and acute atrial clots [2]. In the
neonatal population, recombinant tissue plasminogen activator
(rt-TPA) is the most widely used agent as it has several advantages
including a short half-life, minimal antigenicity, high ﬁbrin speci-
ﬁcity with poor activation of free plasmin [4]. Very closemonitoring
is also vital during the therapy and rt-TPA should be discontinued
once the clot has lysed [2]. Surgical intervention should be the last
option, with the main aim being to maximize the chances of limb
salvage in the rare cases of life or limb-threatening thrombosis [4].
Nevertheless, all interventions are not without their risks and
complications. The main concern with anti-thrombotic therapy in
this population would be intracranial hemorrhage [2]. Therefore,
prior to initiating treatment, the clinician should assess the infant
and only proceed if the potential beneﬁts outweigh the risks.
With regards to long-term outcomes and prognosis of neonatal
aortic thrombosis, more information is still required, but Nagel et al.
showed that 82% of neonates with aortic thrombosis survived till
hospital discharge, and there was a mortality rate of 15% [7].3. Conclusion
In conclusion, this article presents a case of neonatal aortic
thrombus presenting with NEC-like symptoms, requiring treatment
with enoxaparin. Therefore, in a neonate with such symptoms,
aortic thrombus should also be considered as a differential diag-
nosis, especially when laboratory and radiographic ﬁndings are not
strongly suggestive of NEC. In the neonatal population, manage-
ment of neonatal arterial thrombosis remains controversial and
further studies are warranted to guide clinicians.References
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